The accepted paper, titled "Evaluation of Urcosimod in Neuropathic Corneal Pain: Efficacy and Safety Results from a Proof-of-Concept Pilot Phase 2 Study", will be presented in the Ocular Surface ...

Q4 2025 Earnings Call January 30, 2026 11:00 AM ESTCompany ParticipantsPeter Shaw - Vice President of Investor ...

A new comprehensive analysis has revealed that major depressive disorder alters both the physical architecture and the ...

Scientists have developed a new human-based endometrial model to study embryonic implantation in the early stages of pregnancy.

The agreement grants Repertoire an upfront payment of $85m, with the possibility of up to $1.84bn in additional milestone payments.

Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...

Hackathons using AlphaGenome and other AI models are hunting down the genetic causes of devastating conditions that have ...

T cells sit at the center of modern immunotherapy, yet many of the rules that govern their activation, differentiation, dysfunction (e.g., exhaustion), and ...

During H1 2025, the energy storage cell industry navigated triple disruptions—policy overhauls, large-cell transitions, and foreign competitor influx. Market players aggressively captured ...

Researchers have developed a way to grow a highly specialized subset of brain nerve cells that are involved in motor neuron disease and damaged in spinal injuries. Their study, published today in ...